Belgium· BE-AMP-SAM662084-00
Zilbrysq 23 mg
A zilucoplan product containing zilucoplan sodium, registered in Belgium by UCB Pharma. The same ATC class is registered in 13 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Zilucoplan is registered in 13 of 19 countries.
Countries holding a registration under ATC L04AJ06 (zilucoplan), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 8 of them publish a price we can compare per daily dose
Zilucoplan · ATC L04AJ06
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Zilucoplan Sodium
- Manufacturer
- UCB Pharma
- Country
- Belgium (BE)
- ATC code
- L04AJ06
- ATC class
- Zilucoplan
- Defined daily dose
- 23 mg, P
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb4829511
- be_apb7741960
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Zilucoplan in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaZILBRYSQUCB Pharma SA, Brusel
- SpainZILBRYSQ 23 MG SOLUCION INYECTABLE EN PLUMA PRECARGADAUcb Pharma
- SwedenZILBRYSQ 23 mg Injektionsvätska, lösning i förfylld injektionspennaUCB Pharma S.A.
- IcelandZilbrysqUCB Pharma S.A.*
- PolandZilbrysqUCB Pharma S.A.
- SwitzerlandZilbrysq 23 mg, solution pour injection en seringue pré-remplieUCB-Pharma SA
- FinlandZilbrysqUCB Pharma SA
- NetherlandsZilbrysq 16,6 mg oplossing voor injectie in een voorgevulde penUCB Pharma S.A.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Zilbrysq
- Liechtenstein · Zilbrysq
- Norway · Zilbrysq
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/24492ab5-a29b-459e-9cba-951f26a86e6e GET /v1/drugs/24492ab5-a29b-459e-9cba-951f26a86e6e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection in pre-filled syringe",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Zilbrysq 23 mg",
"name_fr": "Zilbrysq 23 mg",
"name_nl": "Zilbrysq 23 mg",
"amp_code": "SAM662084-00",
"strengths": [
"40.0000",
"40.0000"
],
"pack_count": 2,
"substances": [
"Zilucoplan Sodium",
"Zilucoplan",
"Disodium Phosphate",
"Sodium Dihydrogen Phosphate Monohydrate",
"Sodium Chloride"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Zilucoplan",
"authorisation_numbers": [
"EU/1/23/1764/004",
"EU/1/23/1764/003"
]
}See everything about zilucoplan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.